Prange Pharma is a privately held pharmaceutical company headquartered in Plettenberg, Germany, and part of the broader Prange Group, a family-owned organisation with investments across multiple industries. Founded in 2017, the company operates as both a pharmaceutical services provider and an investment platform within the healthcare sector.

The company’s activities span contract development and manufacturing (CDMO), product commercialisation, and licensing, supported by an international network of production and service entities. Its CDMO capabilities are delivered through facilities across Europe and Japan, covering a range of dosage forms and manufacturing processes. In parallel, Prange Pharma manages and markets proprietary pharmaceutical and healthcare products through affiliated companies.

Prange Pharma also plays a strategic role within the Prange Group’s pharmaceutical portfolio, supporting growth through acquisitions, operational development, and integration of manufacturing assets. The group itself has a long track record of building and expanding pharmaceutical businesses globally.

Key products and services

Contract Development and Manufacturing (CDMO):
Ampoules and suppositories production (France)
Semi-solid formulations such as creams, ointments, and gels (Germany)
Inspection and packaging services (Japan)

Pharmaceutical product commercialisation:

Prescription (Rx) and over-the-counter (OTC) products
Medical devices and cosmetics
Dietary supplements

Animal health and feed products:

Feed supplements and parasite control solutions

Licensing and intellectual property management:

Management of licensing projects and pharmaceutical IP

Consulting and data services:

Statistical analysis for validated reporting (APR/PQR)
Shelf-life estimation and product trending

Investment and M&A activities:

Acquisition and development of pharmaceutical manufacturing assets
Expansion of global CDMO capabilities

Overall, Prange Pharma combines CDMO and contract manufacturing capabilities with commercial and investment expertise, positioning itself as an integrated partner across the pharmaceutical value chain. Through its international footprint and affiliation with the Prange Group, the company supports both internal product portfolios and third-party clients in global markets.